News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

TPG Biotech to Fund Development of JCR Pharmaceuticals Drug Candidates


3/12/2008 9:30:33 AM

TOKYO--(BUSINESS WIRE)--TPG Biotech and JCR Pharmaceuticals Co., Ltd. of Ashiya, Japan jointly announced that they have entered into an Investment Agreement to fund the late-stage clinical development of two promising drug candidates for JCR, JR-013 and Growject®. Terms of the agreement were not disclosed.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES